Project Grant HT94252310223
Award Date
4/1/23
Completion Date
3/31/26
Dollars Obligated
$865K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Oklahoma City, OK 73104, USA
Similar Awards
The Department of the Army Medical Command has awarded a $427,109 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the University of Oklahoma Health Sciences Center. The grant, awarded on May 15, 2025, will fund research targeting DCLK1-mediated glutamine addiction in chemoresistant ovarian cancer metastases. This project aims to transform healthcare for military service members and the general public through innovative and impactful medical research....
The University of Oklahoma Health Sciences Center was awarded a $541,837 Project Grant from the Department of Defense's Military Medical Research and Development (CFDA 12.420) program. The grant, titled "DRUG-TARGETING ORP4 AS A PRECISION OVARIAN CANCER TARGET," will fund research aimed at developing new cancer prevention and treatment strategies for ovarian cancer. The award period runs from May 1, 2025 through April 30, 2029. The grant supports advanced biomedical research...
The federal Project Grant award for "DRUG-TARGETING ORP4 AS A PRECISION OVARIAN CANCER TARGET" was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $1,144,000.00 award, which runs from May 1, 2025 to April 30, 2029, supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the general public. The University of Oklahoma Health Sciences Center, the award...
The University of Oklahoma (OU) was awarded a $1,051,250 Project Grant from the Defense Health Agency to conduct research on the re-expression of miR-195 as a therapeutic strategy for chemoresistant ovarian cancer. This research falls under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform health care for service members and the American public. The project is scheduled to run from August 15, 2023, to August 14, 2027. As a public...
The University of Oklahoma Health Sciences Center Division has been awarded a $144,992 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from November 1, 2024 to October 31, 2026, will support advanced biomedical research focused on "Vascular Regulation of Immunosuppression in Glioblastoma." The funding will enable the university to conduct...
The University of Oklahoma's Health Sciences Center Division was awarded a $717,750 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to investigate one-carbon metabolic alterations to target pancreatic cancer cachexia. The research effort aims to develop new treatments and improve patient care for this condition, which is a major concern for service members and veterans. The three-year project will be conducted in Oklahoma City,...
The Defense Health Agency has awarded a $968,400 Project Grant to Mayo Clinic to develop a personalized approach to treating drug-resistant ovarian cancer. The grant, which began on June 1, 2024, and will run through May 31, 2028, is funded under the Military Medical Research and Development program (CFDA 12.420). This program supports biomedical research to improve the health and care of military service members, veterans, and their families. Through this award, Mayo Clinic will leverage its...
The University of Pittsburgh was awarded a $954,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from May 2023 to May 2026 aimed at epigenetic reprogramming to target senescent ovarian cancer cells and overcome therapeutic resistance. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The U.S. Department of Defense's Defense Health Agency awarded Oklahoma State University a $1,234,405 Block Grant under the Military Medical Research and Development program (CFDA 12.420) on June 1, 2024. The grant supports a multi-year research partnership to develop innovative biomedical solutions relevant to military personnel and the broader public. Through this funding, Oklahoma State University will conduct a comprehensive range of investigative projects across disciplines such as cancer...
This Project Grant from the Defense Health Agency provides $494,811 to the University of Cambridge under the Military Medical Research and Development program (CFDA 12.420) from April 1, 2023 to March 31, 2026. The grant funds research to elucidate and target clonal lineages influencing resistance to therapy in distinct mutational subtypes of high-grade ovarian serous carcinoma. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to...